Skip to main content

Table 3 Parameters of VWF function in hereditary VWD patients

From: The effect of recombinant versus plasma-derived von Willebrand factor on prolonged PFA closure times in ECMO patients with acquired von Willebrand syndrome – an observational study

Patient

Diagnosis

VWF activity (IU/dl)

VWF antigen (IU/dl)

VWF Activity/Antigen ratio

1

VWS type 1

42

39

0.93

2

VWS type 1 (Vicenza)

10

10

1

3

VWS type 2A (2C Miami)

166

14

0.08

  1. Values are presented for each patient individually